{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9655734", "DateCompleted": {"Year": "1998", "Month": "07", "Day": "30"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1073-449X", "JournalIssue": {"Volume": "158", "Issue": "1", "PubDate": {"Year": "1998", "Month": "Jul"}}, "Title": "American journal of respiratory and critical care medicine", "ISOAbbreviation": "Am J Respir Crit Care Med"}, "ArticleTitle": "Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone.", "Pagination": {"StartPage": "226", "EndPage": "232", "MedlinePgn": "226-32"}, "Abstract": {"AbstractText": ["Ozone exposure has been related to adverse respiratory effects, in particular to lung function decrements. Antioxidant vitamins are free-radical scavengers and could have a protective effect against photo-oxidant exposure. To evaluate whether acute effects of ozone on lung functions could be attenuated by antioxidant vitamin supplementation, we conducted a randomized trial using a double-blind crossover design. Street workers (n = 47) of Mexico City were randomly assigned to take daily a supplement (75 mg vitamin E, 650 mg vitamin C, 15 mg beta carotene) or a placebo and were followed from March to August 1996. Pulmonary function tests were done twice a week at the end of the workday. During the follow-up, the mean 1-h maximum ozone level was 123 ppb (SD = 40). During the first phase, ozone levels were inversely associated with FVC (beta = -1.60 ml/ppb), FEV1 (beta = -2.11 ml/ppb), and FEF25-75 (beta = -4.92 ml/ppb) (p < 0.05) in the placebo group but not in the supplement group. The difference between the two groups was significant for FVC, FEV1, and FEF25-75 (p < 0.01). During the second phase, similar results were observed, but the lung function decrements in the placebo group were smaller, suggesting that the supplementation may have had a residual protective effect on the lung. These results need to be confirmed in larger supplementation studies."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pan American Health Organization; Instituto Nacional de Salud Publica, Cuernavaca, Mor; Instituto de Investigacion en Matematica Aplicada y Sistemas, Universidad Autonoma de Mexico, Mexico DF. iar9@cdc.gov"}], "Identifier": [], "LastName": "Romieu", "ForeName": "I", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Meneses", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ramirez", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ruiz", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Perez Padilla", "ForeName": "R", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sienra", "ForeName": "J J", "Initials": "JJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gerber", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Grievink", "ForeName": "L", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dekker", "ForeName": "R", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Walda", "ForeName": "I", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brunekreef", "ForeName": "B", "Initials": "B"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Crit Care Med", "NlmUniqueID": "9421642", "ISSNLinking": "1073-449X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "01YAE03M7J", "NameOfSubstance": "beta Carotene"}, {"RegistryNumber": "1406-18-4", "NameOfSubstance": "Vitamin E"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Occupational Diseases"}, {"QualifierName": [], "DescriptorName": "Occupational Exposure"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects"], "DescriptorName": "Respiration"}, {"QualifierName": [], "DescriptorName": "Respiratory Function Tests"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Respiratory Tract Diseases"}, {"QualifierName": [], "DescriptorName": "Spirometry"}, {"QualifierName": ["blood"], "DescriptorName": "Vitamin E"}, {"QualifierName": ["blood", "therapeutic use"], "DescriptorName": "beta Carotene"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "7", "Day": "9"}, {"Year": "1998", "Month": "7", "Day": "9", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "7", "Day": "9", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9655734", "10.1164/ajrccm.158.1.9712053"]}}], "PubmedBookArticle": []}